Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: A study using the National Healthcare Group Diabetes Registry in Singapore

被引:8
|
作者
Ang, Yee Gary [1 ]
Wu, Christine Xia [1 ]
Toh, Matthias Paul Han Sim [1 ]
Chia, Kee Seng [2 ]
Heng, Bee Hoon [1 ]
机构
[1] Natl Healthcare Grp, Singapore 149547, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore
关键词
diabetes mellitus; impaired fasting glycemia; Singapore; LIFE-STYLE INTERVENTION; FOLLOW-UP; GLUCOSE-TOLERANCE; RISK; POPULATION; REDUCTION;
D O I
10.1111/j.1753-0407.2011.00169.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aims of the present study were to estimate the rate of progression from newly diagnosed impaired fasting glycemia (IFG) to type 2 diabetes mellitus (T2DM) in Singapore and to identify factors associated with the progression to T2DM in individuals with newly diagnosed IFG. Methods: The present study was a retrospective cohort study of newly diagnosed IFG from the National Healthcare Group Diabetes Registry between 1 January 2006 and 31 December 2007 to estimated the rate of progression to T2DM. Univariate survival analysis, followed by multivariate survival analysis, was performed and interactions were tested in the final model. Results: Over a mean follow-up period of 1.65 +/- 0.13 years, 85 of 490 participants with newly diagnosed IFG developed T2DM, giving an annual progression rate of 6.8%. The factors associated with the development of T2DM were higher fasting plasma glucose level in the year of IFG diagnosis (hazard ratio [HR] = 14.6; 95% confidence interval [CI] 5.66-37.5), Chinese race (HR = 2.70; 95% CI 1.44-5.06), and body mass index (HR = 1.11; 95% CI, 1.06-1.15). Conclusions: The progression rate to T2DM is high in subjects with newly diagnosed IFG. Intensive lifestyle modification can be incorporated into their current yearly follow-up to prevent progression to T2DM, which is a growing problem in Singapore.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [1] The Singapore National Healthcare Group Diabetes Registry - Descriptive Epidemiology of Type 2 Diabetes Mellitus
    Heng, Bee Hoon
    Sun, Yan
    Cheah, Jason T. S.
    Jong, Michelle
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (05) : 348 - 352
  • [2] Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus
    Su, Ying
    Liu, Xiao-Min
    Sun, Yan-Ming
    Wang, Yue-Ying
    Luan, Ying
    Wu, Yun
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (04): : 497 - 498
  • [3] Progression from newly acquired impaired fasting glusose to type 2 diabetes
    Nichols, Gregory A.
    Hillier, Teresa A.
    Brown, Jonathan B.
    [J]. DIABETES CARE, 2007, 30 (02) : 228 - 233
  • [4] Diabetic retinopathy in newly diagnosed Type 2 diabetes mellitus: Prevalence and predictors of progression; a national primary network study
    Shah, Savan
    Feher, Michael
    McGovern, Andrew
    Sherlock, Julian
    Whyte, Martin B.
    Munro, Neil
    Hinton, William
    Gatenby, Piers
    de Lusignan, Simon
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 175
  • [5] Circulating Netrin-1 as a Novel Biomarker for Impaired Fasting Glucose and Newly Diagnosed Type 2 Diabetes Mellitus
    Jung, Hye-In
    Bae, Jaehyun
    Han, Eugene
    Kim, Gyuri
    Lee, Ji-Yeon
    Kim, So Ra
    Lee, Byung-Wan
    Kang, Eun Seok
    Ahn, Chul Woo
    Cha, Bong-Soo
    Lee, Yong-Ho
    [J]. DIABETES, 2018, 67
  • [6] Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
    Ma, Yuhang
    Wang, Yufan
    Huang, Qianfang
    Ren, Qian
    Chen, Su
    Zhang, Aifang
    Zhao, Li
    Zhen, Qin
    Peng, Yongde
    [J]. JOURNAL OF DIABETES RESEARCH, 2014, 2014
  • [7] Retinopathy in newly diagnosed type 2 diabetes mellitus
    Al-Zuabi, H
    Al-Tammar, Y
    Al-Moataz, R
    Al-Sabti, K
    Wani, VB
    Hamama, F
    Mohammad, H
    Al-Suwayan, MH
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2005, 14 (05) : 293 - 296
  • [8] Prevalence of impaired fasting glucose, impaired glucose tolerance and newly-diagnosed diabetes in subjects at risk of developing type 2 diabetes
    Tankova, T.
    Chakarova, N.
    Lazarova, M.
    Atanassova, I.
    [J]. DIABETOLOGIA, 2007, 50 : S163 - S163
  • [9] The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study
    Li, Boyu
    Hu, Yanjin
    Wang, Guang
    Liu, Lihong
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [10] The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study
    Boyu Li
    Yanjin Hu
    Guang Wang
    Lihong Liu
    [J]. BMC Pharmacology and Toxicology, 21